Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
Authors
Keywords
-
Journal
mAbs
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2019-04-16
DOI
10.1080/19420862.2019.1608143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation
- (2018) Chiu-Ping Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
- (2018) Masato Kiyoshi et al. Scientific Reports
- Effects of amino acid substitutions on the biological activity of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
- (2018) Michihiko Aoyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A single amino acid distorts the Fc γ receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a
- (2018) Jacob T. Roberts et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms
- (2018) Ryuta Wada et al. mAbs
- Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
- (2017) Simon A. Mortensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IgG Fc engineering to modulate antibody effector functions
- (2017) Xinhua Wang et al. Protein & Cell
- Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity
- (2017) Benjamin Peschke et al. Frontiers in Immunology
- Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
- (2017) Wei Li et al. Frontiers in Immunology
- Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins
- (2016) John P. Giddens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies
- (2016) Marco Thomann et al. MOLECULAR IMMUNOLOGY
- Fc glycans of therapeutic antibodies as critical quality attributes
- (2015) Dietmar Reusch et al. GLYCOBIOLOGY
- Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods
- (2015) Dietmar Reusch et al. mAbs
- Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
- (2015) Minoru Tada et al. mAbs
- The Structural Role of Antibody N-Glycosylation in Receptor Interactions
- (2015) Ganesh P. Subedi et al. STRUCTURE
- Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
- (2015) Masami Suzuki et al. Journal of Toxicologic Pathology
- In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
- (2015) Marco Thomann et al. PLoS One
- Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities
- (2015) Masaki Kurogochi et al. PLoS One
- Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
- (2015) Tetyana Dashivets et al. PLoS One
- Development of a Cell-Based Assay Measuring the Activation of FcγRIIa for the Characterization of Therapeutic Monoclonal Antibodies
- (2014) Minoru Tada et al. PLoS One
- Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab
- (2013) Jan Visser et al. BIODRUGS
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions
- (2012) Wei Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Galactosylation variations in marketed therapeutic antibodies
- (2012) T. Shantha Raju et al. mAbs
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection
- (2012) ANNA FRITZ-RDZANEK et al. Oncology Letters
- Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions
- (2010) Shiyi Wang et al. JOURNAL OF CHROMATOGRAPHY A
- Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
- (2010) Damian Houde et al. MOLECULAR & CELLULAR PROTEOMICS
- Efficient Synthesis of Sugar Oxazolines from UnprotectedN-Acetyl-2-amino Sugars by Using Chloroformamidinium Reagent in Water
- (2009) Masato Noguchi et al. JOURNAL OF ORGANIC CHEMISTRY
- Terminal sugars of Fc glycans influence antibody effector functions of IgGs
- (2008) T Shantha Raju CURRENT OPINION IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started